Replies to post #327807 on Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

I am not upset or surprised by the response you received.

There won't be any convincing data until the peer review articles come out - as I believe they will come out prior to any other statements from the RBLs.

Until then, nothing for medical types to review so we wait. But when that day comes, should gather LOTS of attention across the medical spectrum.

[TheDane]

Oh well, I guess that’s it then. Who is Dr. Argus?

[Jhawker]

I think that could be said about most therapeutics right now.

[Rdunn88]

Exactly, no convincing data except from source Leo!!! That's worth 22 pennies per/share.

[zandant]

Wow. So despite Leo's excitement in his press releases, this doctor is saying that there is no convincing data that B "the wonder drug" is a viable covid therapeutic? Or am I misinterpreting your post?

[LIVED]

Isn't Dr. Agus a cancer Dr.? If so, maybe we should send him the Kevetrin abstract from our friends the Italian cancer scientists. See what he thinks; or recommendations or referrals he could make.

[farrell90]

That means to me either he did not review the in vitro data reported or the only data he feels is revalent is clinical trial data.

Hopefully we can give him some good clinical trial data soon.

Good luck to all, Farrell

[Justfactsmam]

Dr. Debones...you stated:

Dr. David Agus responded to me regarding Brilacidin. He’s following but states there is “no convincing data.”

Exactly WHAT DATA was Dr. Agus PRIVY TOO?...the answer is NONE.
TIAB has been crying for data behind the RBL results...and he has found none...one of his biggest complaints...

BUT THE FACT IS there has not been a release of data from the RBL tests...the only information released and to be released before the Pre-print PEER review articles were those data points revealed to the company by the RBLs and stated in the PRs.

So when he says "no convincing data" he is not saying the data is bad...he can only means there is no data from which he can draw a conclusion....ONE WAY OR THE OTHER!

...and we all knew that! Wait for the Pre-Print ... then ask the same question...likely a much different response

!

[roiresearch]

Didn't you have a similar experience with another expert toward the end of September? Again, i appreciate the exposure you and others are bring to B on twitter, but there will be a roadblock when it comes to additional information other than what we have seen via pr

https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap
According to the ctap dashboard, there are more than 550 drug development programs in planning stages and 350 trials reviewed by the fda. Is B the needle in the haystack? Hope so